NCT02808650 2023-12-20Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid TumorsChildren's Oncology GroupPhase 1 Completed30 enrolled 16 charts
NCT02873975 2022-10-21A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair DeficiencyDana-Farber Cancer InstitutePhase 2 Completed27 enrolled 13 charts